Pricing Log in Create free account

Abivax SA Sponsored ADR (ABVX) vs Protagonist Therapeutics, Inc. (PTGX)

Abivax SA Sponsored ADR and Protagonist Therapeutics, Inc. are both Biotechnology companies. Abivax SA Sponsored ADR and Protagonist Therapeutics, Inc. are of similar size ($8.8B and $8.1B). Abivax SA Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Protagonist Therapeutics, Inc. trades at 106×. Protagonist Therapeutics, Inc. has the higher net margin (29.4% vs 0.00%) and the higher return on invested capital (61.8% vs 0.00%). Across the 14 metrics below, Protagonist Therapeutics, Inc. leads on 12 and Abivax SA Sponsored ADR on 2.

Valuation

Metric ABVX PTGX Biotechnology median
P/E n/m 105.53 8.50
P/S n/m 30.10 9.71
P/B 16.42 10.09 2.13
Price to free cash flow n/m 65.01 20.82
EV/EBITDA n/m 136.87 0.64
EV/Sales n/m 27.36 9.21
Earnings yield (6.90%) 0.95% (33.15%)
Free cash flow yield (3.23%) 1.54% (25.50%)

Profitability

Metric ABVX PTGX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 20.69% 0.00%
Net margin 0.00% 29.40% 0.00%
Free cash flow margin 0.00% 46.31% 0.00%
Return on equity (249.78%) 10.98% (56.36%)
Return on assets (137.67%) 10.34% (48.04%)
Return on invested capital 0.00% 61.84% 0.00%

Growth

Metric ABVX PTGX Biotechnology median
Revenue growth (TTM) — 34.81% 6.02%
EPS growth (last fiscal year) (80.20%) (148.46%) 30.26%
Revenue growth, 5-year CAGR — 9.96% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABVX PTGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.97 21.71 4.72
Net debt to EBITDA 2.19 3.49 0.96

Dividend

Metric ABVX PTGX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABVX PTGX Biotechnology median
Market cap 8.09b 8.84b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack